Showing all 3 results
Lamivudine & Zidovudine tablets
FreeProduct Composition & Strength
We supply this product in the internationally standardized Fixed-Dose Combination (FDC) required for therapeutic compliance.
Active Ingredient Strength (per Tablet) Primary Clinical Function Lamivudine (3TC) IP/BP/USP 150 mg The Chain Terminator: High potency, low toxicity. Zidovudine (AZT) IP/BP/USP 300 mg The Foundation: Proven efficacy in preventing replication. Excipients Pharma Grade The Matrix: Ensures stability of the sensitive FDC. Lamivudine Tablets
FreeLamivudine Tablets IP 100 mg
Each Filmcoated tablet contains :
Lamivudine IP 100 mg exceipents Q.S.Lamivudine Tablets IP 150 mg
Each Filmcoated tablet contains :
Lamivudine IP 150 mgLamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg tablets IP Each Film Coated Tablets Contains: Lamivudine IP 150 mg Zidovudine IP 300 mg Nevirapine IP 200 mg Excipients Q.S.
Lamuzy Tablets Lamivudine and Zidovudine Tablets IP
Each Film Coated tablet contains :
Zidovudine IP 300 mg
Lamivudine IP 150 mgCirolam 150 Tablets
Lamivudine Tablets 150 mg
Each Film Coated tablet contains :
Lamivudine USP 150 mgUsage: – Hepatitis B infection
Category: – HIV Anti Viral drugs
Therapeutic category: – Antiviral, Anti HIV, Hepatitis Treatment
Lamivudine, Zidovudine & Nevirapine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often White or Off-White). This FDC is designed for patients who have successfully completed the Nevirapine “lead-in” phase.
Active Ingredient Strength (Standard) Class Lamivudine USP/BP 150 mg NRTI (Cytidine Analog) Zidovudine USP/BP 300 mg NRTI (Thymidine Analog) Nevirapine USP/BP 200 mg NNRTI Excipients Q.S. Microcrystalline Cellulose / Sodium Starch Glycolate
